$CRON

Cronos Group (CRON) expanded its Spinach® brand with new gummy and vape flavors. The SOURZ by Spinach® Blue Raspberry Lemonade Fully Blasted gummies, infused with 100% live resin, and two new vape cartridge flavors are now available in Ontario, with national rollout expected later in 2026. According to the company, Spinach® is Canada’s top edible multipack brand as of June 2026.

Cronos Group Inc. (CRON) filed an SEC Form 8-K — Results of Operations and Financial Condition. Cronos Group Reports 2026 Second Quarter Results Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis Delivered record net revenue in Can

Cronos Group Inc. (CRON) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. cron-20260618 false CRONOS GROUP INC. 0001656472 Stayner Canada 001-38403 Ontario 0001656472 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 193

A federal grand jury in California convicted short seller Andrew Left of securities fraud, the U.S. Justice Department said. He was found guilty of one count of participating in a securities fraud scheme and 12 securities fraud counts. Prosecutors said he profited over $20 million from 2018-2023 via trades tied to Citron Research commentary on companies including Tesla and Nvidia. Sentencing is Aug. 31; he faces up to 25 years.

Activist short seller Andrew Left, founder of Citron Research, was convicted in Los Angeles federal court of securities fraud for allegedly manipulating stock prices using his social-media following. A jury found him guilty on 1 scheme count and 12 securities-fraud counts; prosecutors said he profited about $20 million. He plans to appeal and faces sentencing Aug. 31, with up to 25 years on the lead count.

The article discusses generative AI and robotics potential, citing statements by Amazon CEO Andy Jassy, Elon Musk’s prediction of 10 billion humanoid robots by 2040, and comments from Bill Gates, Larry Ellison and Warren Buffett. It also claims Cronos Group (CRON) shares were rising ahead of Q1 results, but provides no Q1 figures. It promotes a paid newsletter, asserting management cut $100 million in waste and citing “400% upside” for an unspecified “$3” stock.

Cronos Group executive Arye Weigensberg exercised 3,118 restricted stock units (RSUs) into common shares, increasing his direct holdings to 211,555 shares. This compensation-related transaction, reported on May 10, 2026, did not involve any share sales, and Weigensberg retains 154,419 RSUs. The filing is categorized as neutral in its market impact and sentiment.

Cronos Group (TSE:CRON) has announced a new $50 million share repurchase program following a strong first quarter in 2026, which saw a 40% year-over-year revenue increase to $45.2 million and record gross profit. The company also extended the deadline for its CanAdelaar B.V. acquisition to September 2026 to secure necessary Dutch regulatory approvals. Spark, TipRanks’ AI Analyst, rates CRON as Neutral, noting strong financial resilience but weak bottom-line profitability.

This article provides an investment analysis for Cronos Group Inc. (CRON:CA), including AI-generated trading signals for near, mid, and long terms, and recommended trading plans. It suggests buying near 3.24, targeting 3.73, and using a stop loss at 3.22, or shorting near 3.73, targeting 3.24, with a stop loss at 3.75. The analysis is current as of January 5, 2026.

Cronos Group's stock price has risen by 11.93% due to significant investor optimism following its strategic expansion into Europe. The company plans to acquire CanAdelaar, Europe's largest adult-use cannabis sector player, for $67 million, and has also unveiled new Lord Jones Live Resin Fusions pre-rolls in Canada. This move aims to boost Cronos's European footprint and capitalize on evolving cannabis markets.